Role of science in the treatment of breast cancer when tumor multicentricity is present

Journal of the National Cancer Institute

Volumn 103, Issue 17, 2011, Pages 1292-1298

  Fisher, Bernard ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL RESEARCH; DISEASE FREE SURVIVAL; HUMAN; HYPOTHESIS; MASTECTOMY; MEDICAL LITERATURE; MULTIPLE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; EVIDENCE-BASED MEDICINE; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 80052684865     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr240     Document Type: Review

References (50)

1. Fisher B. From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century. Eur J Cancer. 1999;35(14):1963-1973.
2. Fisher B. The surgical dilemma in the primary therapy of invasive breast cancer: a critical appraisal. Curr Probl Surg. 1970;3-53.
3. Fisher B, Fisher ER. Metastasis revisited. In: Weiss L, eds. Fundamental Aspects of Metastasis. New York, NY: North-Holland Publishing Company; 1976:427-435.
4. Fisher B. Laboratory and clinical research in breast cancer-a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res. 1980;40:3863-3874.
5. Fisher B. The interdependence of laboratory and clinical research in the study of metastases. In: Nicolson GL, Milas L, eds. Cancer Invasion and Metastasis: Biologic and Therapeutic Aspects. New York, NY: Raven Press; 1984:27-46.
6. Bernard C. Introduction á Letude de la Médecine Experimentale. Paris, France: J. B. Bailliere; 1865.
7. Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer: a first report of results from a prospective randomized clinical trial. Cancer. 1977;39(6 suppl):2827-2839.
8. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312(11):665-673.
9. Fisher B, Redmond C, Brown A, et al. Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med. 1981;305(1):1-6.
10. Kuhn TS. The Structure of Scientific Revolutions. 2nd ed. Chicago, IL: University of Chicago Press; 1970.
11. Du X, Freeman DH Jr., Syblik DA. What drove changes in the use of breast conserving surgery since the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement. Breast Cancer Res Treat. 2000;62(1):71-79.
12. Nattinger AB, Gottlieb MS, Veum J, et al. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326(17):1102-1107.
13. NIH consensus conference. treatment of early-stage breast cancer. JAMA. 1991;265(3):391-395.
14. Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203-5209.
15. Foote RL, Johnson RE, Donohue JH, et al. Trends in surgical treatment of breast cancer at Mayo Clinic 1980-2004. Breast. 2008;17(6):555-562.
16. Lee MC, Rogers K, Griffith K. Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J. 2009;15(1):34-40.
17. Fisher ER, Gregorio R, Redmond C, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4) I. Observations concerning the multicentricity of mammary cancer. Cancer. 1975;35(1):247-254.
18. Nicholson GW. Carcinoma of the breast. Br J Surg. 1920;8(32):527-528.
19. Cheatle GL, Cutler M. Tumours of the Breast-Their Pathology, Symptoms and Diagnosis and Treatment. Philadelphia, PA: J. B. Lippincott; 1931.
20. Qualheim RE, Gall EA. Breast carcinoma with multiple sites of origin. Cancer. 1957;10(3):460-468.
21. Gallager HS, Martin JE. The study of mammary carcinoma by mammography and whole organ sectioning. Cancer. 1969;23(4):855-873.
22. Fisher B. Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer. Cancer. 1977;40(suppl S1):574-587.
23. Fisher B. Breast-cancer management: alternatives to radical mastectomy. N Engl J Med. 1979;301(6):326-328.
24. Fisher B. Combined modality treatment of cancer. In: Proceedings 13th International Cancer Congress. Vienna, Austria: August 28-September 2, 1983. 1-10.
25. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(347):1233-1241.
26. Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6): II. Relation of local breast recurrence to multicentricity. Cancer. 1986;57(9):1717-1724.
27. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227-1232.
28. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute randomized trial. Cancer. 2003;98(4):697-702.
29. Arriagada R, Le MG, Rochard F, et al; for the Institut Gustave-Roussy Breast Cancer Group. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol. 1996;14(5):1558-1564.
30. Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr. 1992;(11):19-25.
31. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92(14):1143-1150.
32. Early Breast Cancer Trialists Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med. 1995;333(22):1444-1455.
33. Rochon PA, Bero LA, Bay AM, et al. Comparison of review articles published in peer-reviewed and throwaway journals. JAMA. 2002;287(21):2853-2856.
34. Wiley S. Down with reviews. Scientist. 2010;24(4):31.
35. Medawar P. Plutos Republic: Incorporating the Art of the Soluble and Induction and Intuition in Scientific Thought. Oxford, UK: Oxford University Press; 1982.
36. Ahrens EH Jr. The Crisis in Clinical Research: Overcoming Institutional Obstacles. New York, NY: Oxford University Press; 1992.
37. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26(19):3248-3258.
38. Hillman BJ. Do we need randomized controlled clinical trials to evaluate the clinical impact of breast MR imaging? Magn Reson Imaging Clin N Am. 2006;14(3):403-409.
39. Pettit K, Swatske ME, Gao F, et al. The impact of breast MRI on surgical decision-making: are patients at risk for mastectomy? J Surg Oncol. 2009;100(7):553-558.
40. Grobmyer SR, Mortellaro VE, Marshall J, et al. Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy? J Am Coll Surg. 2008;206(5):1045-1052.
41. Braun M, Pölcher M, Schrading S, et al. Influence of preoperative MRI on the surgical management of patients with operable breast cancer. Breast Cancer Res Treat. 2008;111(1):179-187.
42. Solin LJ. Counterview: pre-operative breast MRI (magnetic resonance imaging) is not recommended for all patients with newly diagnosed breast cancer. Breast. 2010;19(1):7-9.
43. Sardanelli F. Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes. Breast. 2010;19(1):3-6.
44. Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375(9714):563-571.
45. Morris EA. Should we dispense with preoperative breast MRI? Lancet. 2010;375(9714):528-530.
46. Peters NHGM, Rinkes IHMB, Mali WPTM, et al. Breast MRI in nonpalpable breast lesions: a randomized trial with diagnostic and therapeutic outcome-MONET-study. Trials. 2007;8:40.
47. Euser AM, Zoccali C, Jager KJ, et al. Cohort studies: prospective versus retrospective. Nephron Clin Pract. 2009;113(3):c214-c217.
48. Retrospective Cohort Study. http://en.wikipedia.org/wiki/Retrospective- cohort-study. Accessed September 24, 2010.
49. Hess DR. Retrospective studies and chart reviews. Respir Care. 2004;49(10):1171-1174.
50. Houssami N, Hayes DF. Review of preoperative magnetic resonance imaging (MRI) in breast cancer. Should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin. 2009;59(5):290-302.